Grab these stocks before they soar
You are receiving this email because you are subscribed to Behind the Markets. If you no longer wish to receive these emails, please unsubscribe here. Prefer to view this content on our website? Click here.
Dear Fellow Investor,
The pullback in cruise stocks is a buying opportunity.
Company: Royal Caribbean (SYM: RCL) Look at Royal Caribbean (SYM: RCL), for example. Even with strong earnings growth, the stock dropped. However, not only did it just catch support at its 50-day moving average, but it's also excessively oversold on RSI and Williams' %R. Helping, RCL just raised its adjusted earnings per share outlook to a new range of $11.35 to $11.45 from an older range of $10.70 to $10.90. The company even reinstated a 40-cent dividend, which is payable on Oct. 11. That, coupled with explosive demand makes Royal Caribbean a strong buy at current prices.
Millionaire Publishing Make this simple trade at 2:59pm on Friday! (Grab it now)
Make this one simple trade at 2:59pm on Friday afternoon...
And you'll thank me on Monday morning.
These few simple moves today could make 2024 your year of financial triumph!
>>>Click here to get the details on the trade.
Company: Carnival (SYM: CCL) Or, look at Carnival (SYM: CCL). Oversold, Carnival recently beat its EPS estimates again. Plus, in its recent report, it said company bookings are at record highs this year and are significantly exceeding 2023 numbers. Even better, the company saw customer deposits hit a record high of $8.3 billion in the second quarter, which was $1.1 billion higher than a prior record high.
Trading Tips 3 Sub-$10 Stocks to Buy for 2024
Feel like you've been priced out of the best tech stocks or are you confused by the biotech market despite the huge gains some of those stocks pay out?
Don't worry, you're not alone.
We've found the perfect way to get you into these industries without breaking the bank.
In fact, we've analyzed thousands of stocks and found THREE that we believe are "perfect buys."
And ALL of them trade for less than $10.
Simply click here, claim your report, and we'll send it to your inbox for FREE.
(By clicking this link you agree to receive emails from Trading Tips and their affiliates. You can opt out at any time)
Company: Norwegian Cruise Line (SYM: NCLH) Also oversold, Norwegian Cruise Line (SYM: NCLH) just beat top and bottom line estimates. EPS of 40 cents beat by six cents. Revenue of $2.4 billion, up 8.6% year over year beat by $20 million. Adjusted EBITDA jumped 14% to $587.7 million. NCLH also raised its full-year adjusted net income guidance by $60 million to about $790 million from $730 million. It also increased its adjusted EPS guidance to $1.53 from $1.43. It's just something to consider if you're looking for opportunities in this crazy market.
Financial Markets Daily Small biotech firm is working on the next revolutionary antiviral medicine
This innovative biotech company is taking a novel, game-changing approach to eradicating many respiratory viruses including the tripledemic threat of COVID, RSV, and the FLU!
As a global leader in broad-spectrum antiviral nanomedicines developing drugs that work safely and effectively even against variants.
Learn more about how NV-387 may become the next revolutionary antiviral medicine.
|
Our mailing address is:
Behind the Markets, LLC
4260 NW 1st Avenue, Suite 55
Boca Raton, FL 33431
Copyright © 2024 Behind the Markets, LLC, All rights reserved.
You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our Privacy Policy or our Legal Notices.
We are issuing this disclosure in compliance with Section 17(b) of the Securities Act, which requires us to disclose any compensation received or expected to be received in cash or in kind in connection with the purchase or sale of any security.
We would like to inform you that we have received or expect to receive compensation in connection with the purchase or sale of the securities of NanoViricides, Inc. (NYSE American: NNVC). The compensation consists of up to $3,000 and was received/will be received from Interactive Offers.
This compensation should not be considered as an endorsement of the securities of adviser NanoViricides, Inc. (NYSE American: NNVC) and we are not responsible for any errors or omissions in any information provided about the securities of NanoViricides, Inc. (NYSE American: NNVC) and Financial Markets Daily.
We encourage you to conduct your own due diligence and research before making any investment decisions. You should also consult with a financial advisor before making any investment decisions.
This disclosure is made as of 7/31/24.
Behind the Markets
Unsubscribeinvisiblelink
|
|
Tidak ada komentar:
Posting Komentar